Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple support strategies may help curb hepatitis c in appalachia

NCT ID NCT05397067

Disease control Sponsor: Carilion Clinic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This study tests whether offering peer support, small incentives, telehealth visits, or prepaid phones helps people with hepatitis C and substance use disorders get linked to medical care. Participants are adults in Appalachia who have tested positive for hepatitis C and have a history of substance use. The goal is to find low-cost, community-based ways to improve care access and reduce the spread of hepatitis C.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
peer support, incentives, telehealth visits, prepaid phones
What this could lead to
If successful, this approach could help more people with hepatitis C and substance use disorders get linked to treatment, reducing the spread of the virus.
What could go wrong
This is a small study in one region, so results may not apply everywhere. The interventions may not significantly improve care linkage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

60 people

The number who actually took part.

Started

Jul 2022

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: * 18 years or older, positive Hepatitis C antibody test, * elevated Hepatitis C RNA * history of substance use disorder Exclusion criteria: * under 18 years old, * history of treatment of Hepatitis C infection

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hepatitis C, chronic are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis C virus infection hepatitis C virus infection substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hepatitis C, chronic Substance use disorders

Contacts and locations

Locations

  • Carilion Clinic

    Roanoke, Virginia, 24014, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.